Histogenics Corporation - Product Pipeline Analysis, 2013 Update - New Market Study Published
Histogenics Corporation (Histogenics) is a regenerative medicine company. The company develops and manufactures tissue regeneration products for the orthopedic markets. Its products include vericart auto-regenerative cartilage matrix and neocart implant. Histogenics's vericart product offers an alternative for treating discrete cartilage defects. The company's products focus on the treatment of active patients suffering from articular cartilage derived pain and immobility. It manufactures products to improve the body's ability to regenerate healthy cartilage, improve joint function and prevent degenerative disease. The company...
View full press release